Page last updated: 2024-11-03

propofol and Hyperthyroid

propofol has been researched along with Hyperthyroid in 7 studies

Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"Hyperthyroidism patients experience a shorter onset time, a shorter duration, and require larger doses of rocuronium than euthyroidism patients."7.74Hyperthyroidism patients have shorter onset and duration time of rocuronium than euthyroidism patients. ( Feng, SW; Ge, YL; He, LL; Song, XJ; Wang, YG; Yang, JJ, 2007)
"We managed two patients with secondary hyperthyroidism due to TSH secretion from pituitary adenomas using total intravenous anesthesia with propofol and fentanyl."7.72[Anesthetic management with propofol, fentanyl TCI and BIS in two cases of secondary hyperthyroidism due to TSH secretion from pituitary adenomas]. ( Kamata, K; Nagata, O; Nishiyama, K; Ozaki, K; Ozaki, M; Uezono, S, 2003)
"We investigated propofol pharmacokinetics in a patient with secondary hyperthyroidism caused by thyroid stimulating hormone (TSH) producing pituitary adenoma."7.71[Propofol pharmacokinetics in a patient with TSH producing pituitary adenoma]. ( Ishizuka, S; Kobayashi, T; Tsubokawa, T; Yamamoto, K, 2001)
"We investigated propofol pharmacokinetics in seven hyperthyroid (Group H) and eight euthyroid (Group E) patients undergoing elective subtotal thyroidectomy."7.70Propofol clearance and distribution volume increase in patients with hyperthyroidism. ( Kobayashi, T; Tsubokawa, T; Yamamoto, K, 1998)
"Hyperthyroidism patients experience a shorter onset time, a shorter duration, and require larger doses of rocuronium than euthyroidism patients."3.74Hyperthyroidism patients have shorter onset and duration time of rocuronium than euthyroidism patients. ( Feng, SW; Ge, YL; He, LL; Song, XJ; Wang, YG; Yang, JJ, 2007)
"We managed two patients with secondary hyperthyroidism due to TSH secretion from pituitary adenomas using total intravenous anesthesia with propofol and fentanyl."3.72[Anesthetic management with propofol, fentanyl TCI and BIS in two cases of secondary hyperthyroidism due to TSH secretion from pituitary adenomas]. ( Kamata, K; Nagata, O; Nishiyama, K; Ozaki, K; Ozaki, M; Uezono, S, 2003)
"Serum samples from patients with hypo- (n=33) and hyperthyroidism (n=33) and also from healthy volunteers (control group; n=9) were spiked with propofol to a total (bound + unbound propofol) concentration of 10 microg/ml."3.71'In vitro' binding of propofol to serum lipoproteins in thyroid dysfunction. ( Calvo, R; de la Fuente, L; Jauregizar, N; Lukas, JC; Suárez, E; Vázquez, JA, 2002)
"We investigated propofol pharmacokinetics in a patient with secondary hyperthyroidism caused by thyroid stimulating hormone (TSH) producing pituitary adenoma."3.71[Propofol pharmacokinetics in a patient with TSH producing pituitary adenoma]. ( Ishizuka, S; Kobayashi, T; Tsubokawa, T; Yamamoto, K, 2001)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's6 (85.71)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de la Fuente, L1
Lukas, JC1
Vázquez, JA1
Jauregizar, N1
Calvo, R1
Suárez, E1
Kamata, K1
Nagata, O1
Ozaki, K1
Nishiyama, K1
Uezono, S1
Ozaki, M1
Wang, YG1
Song, XJ1
Feng, SW1
Ge, YL1
Yang, JJ1
He, LL1
Tsubokawa, T2
Yamamoto, K2
Kobayashi, T2
Matsumoto, S1
Unoshima, M1
Takeshima, N1
Yamamoto, H1
Yoshitake, S1
Noguchi, T1
Ishizuka, S1
Nishio, W1
Takahata, O1
Yamamoto, Y1
Mamiya, K1
Iwasaki, H1

Other Studies

7 other studies available for propofol and Hyperthyroid

ArticleYear
'In vitro' binding of propofol to serum lipoproteins in thyroid dysfunction.
    European journal of clinical pharmacology, 2002, Volume: 58, Issue:9

    Topics: Adult; Aged; Anesthetics, Intravenous; Blood Proteins; Cholesterol; Female; Humans; Hyperthyroidism;

2002
[Anesthetic management with propofol, fentanyl TCI and BIS in two cases of secondary hyperthyroidism due to TSH secretion from pituitary adenomas].
    Masui. The Japanese journal of anesthesiology, 2003, Volume: 52, Issue:8

    Topics: Adenoma; Anesthesia, Intravenous; Fentanyl; Humans; Hyperthyroidism; Male; Middle Aged; Monitoring,

2003
Hyperthyroidism patients have shorter onset and duration time of rocuronium than euthyroidism patients.
    Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2007, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Androstanols; Body Temperature; Humans; Hyperthyroidism; Middle Aged; Neuromuscul

2007
Propofol clearance and distribution volume increase in patients with hyperthyroidism.
    Anesthesia and analgesia, 1998, Volume: 87, Issue:1

    Topics: Adult; Anesthetics, Intravenous; Blood Proteins; Female; Hemoglobins; Humans; Hyperthyroidism; Male;

1998
[Hemodynamic effects of propofol as an anesthesia induction agent in hyperthyroidism patients on chronic beta-blocker].
    Masui. The Japanese journal of anesthesiology, 2000, Volume: 49, Issue:9

    Topics: Adrenergic beta-Antagonists; Adult; Anesthetics, Intravenous; Drug Interactions; Female; Hemodynamic

2000
[Propofol pharmacokinetics in a patient with TSH producing pituitary adenoma].
    Masui. The Japanese journal of anesthesiology, 2001, Volume: 50, Issue:2

    Topics: Adenoma; Anesthesia Recovery Period; Anesthesia, General; Anesthetics, Intravenous; Half-Life; Human

2001
[Perioperative management using propofol in a patient with uncontrolled preoperative hyperthyroidism].
    Masui. The Japanese journal of anesthesiology, 2001, Volume: 50, Issue:6

    Topics: Adult; Anesthesia, Intravenous; Anesthetics, Intravenous; Female; Humans; Hyperthyroidism; Periopera

2001